Table 1: Lp(a) values in patients that developed atherosclerotic disease.

CasesControls
Lp(a)
(mg/dL)
Lp(a)
(mg/dL)
Years of follow up Year of the study

Alfthan et al. [56]
 Males9773148108
 Females9711312191 8 1994
Assmann et al. [57]33908285081996
Coleman et al. [58]494021922881–91992
Cremer et al. [59]10718051249051994
Jauhiainen et al. [60]1381311301116-71991
Klausen et al. [61]74124190948 or 151997
Ridker et al. [62]296103296102.55.021995
Rosengren et al. [63]26277.7109172.761990
Schaefer et al. [64]2332373901957–101994
Sigurdsson et al. [65]10423012281708.61992
Wald et al. [66]22985.8114555.65–121994
Wild et al. [67]
 Males90125.19063.5
 Females4497.34472.7 13 1997
Bostom et al. [68]305>303103121994
Bostom et al. [69]129219115.41996
Cantin et al. [70]116>30215651998
Cressman et al. [71]38.412916.941992
Stubbs et al. [71]>30266 
197
31998
Kronenberg and Utermann [72]32.88268.851999
Bennet et al. [72]204743.8392140.4122008
Dahlén et al. [73]62250.2124134.7111998
Cantin et al. [70]116
with IHD
41 204032.751998
Nguyen et al [74]993632.88268.8141997
Ariyo et al. [72]39724.27.42003
Hoogeveen et al. [75]5712.65469.152001
Dirisamer et al. [76]10320103152002